A laboratory within Evotec’s Framingham, MA, facility shortly after the company completed the site for...
Industry News
Avidity Biosciences found an eager buyer for its neuroscience pipeline when Novartis shelled out approximately...
The year has gotten off to a warm start, though not quite red hot, when...
uniQure (NASDAQ: QURE) shares finished the regular trading week down only 9% despite the FDA’s...
Baisong Mei, Anna O’Driscoll chat with City Therapeutics CEO Andy Orth. City Therapeutics, a...
Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s most advanced immuno-oncology asset, the...
A researcher working at Kite, a Gilead Company. Kite’s parent company Gilead Sciences has agreed...
Credit: Alfred Pasieka/Science Photo Library/Getty Images The FDA Commissioner’s National Priority Review Voucher (CNPV) Pilot...
Moderna researchers at work in the company’s lab. The FDA’s reversal of its earlier refusal...
As it celebrates its 15th anniversary this year, Foresite Capital is looking less back than...









